BIT's 10th Annual World Cancer Congress -2017 (WCC-2017)
★ Scientific Program
Preliminary Program

Session times on those days will not be finalized until the overall program schedule is completed.


Program Tracks (Please click each Track for detailed program information)
Track 1: Opening Ceremony and Keynote Forum
Track 2: Breakthroughs in Cancer Research
Track 3: Cancer Prognostics and Diagnostics
Track 4: Novel Cancer Therapeutics
Track 5: Latest Anti-cancer Drug Discovery
Track 6: Medical Research on Tumors


Track 1: Opening Ceremony and Keynote Forum

Time: 09:30-12:10, May 19th, 2017 (Friday)
Moderator Call for Moderator
09:40-09:45 Moderator's Introduction
09:45-10:10 Title: Rational Targeted Therapies for Advanced Prostate Cancer
Dr. Paul S. Rennie, Professor & Director, Laboratory Research, The Vancouver Prostate Centre & University of British Columbia, Canada
10:10-10:35 Title: The Future of Radiotherapy
Dr. Karol Sikora, Chief Medical Officer & Dean, Proton Partners International & University of Buckingham Medical School, UK
10:35-11:00 Title: “Hormonal Carcinogenesis” – With Special Emphasis on Testis and Ovaries
Dr. Bennard van Ravenzwaay,
Senior Vice President, BASF SE, Germany
11:00-11:25 Title: TBD
Dr. Stefan J. Scherer, VP & Head Academic Medical Innovation, Novartis Pharmaceuticals Corporation, USA
11:25-11:50 Speech Opportunity Available


Hosting Organization
World High Technology Society
Operating Organization

BIT Group Global Ltd.

International Honorary Chairman

Dr. Thomas Tursz
Professor & Honorary Director
Institut Gustave Roussy, France

Official Media Partner
Official Travel Agency
BIT’s Upcoming Events
Contact Us

Add: East Area, F11, Building 1, Dalian Ascendas IT Park, 1 Hui Xian Yuan, Dalian Hi-tech Industrial Zone, LN 116025, China]
Tel: 0086-411-84799609, Fax: 0086-411-84796897
Copyright © 2014-2015 BIT Congress Inc.